Atlas Trials

Frontline of ASCT in High-risk DLBCL

Clinical trial NCT05831865 · RECRUITING

Trial details

NCT number
NCT05831865
Sponsor
Peking University People's Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Diffuse Large B Cell Lymphoma
Start date
2023-05-03
Primary completion
2025-04-27
Enrollment
175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.